| | 83387-25-1 Basic information More.. |
| Product Name: | methylnaltrexone | | Synonyms: | methylnaltrexone;17-(Cyclopropylmethyl)-4,5α-epoxy-3-methoxy-14-hydroxymorphinan-6-one;3-Methoxy-14-hydroxy-17-(cyclopropylmethyl)-4,5α-epoxymorphinan-6-one;3-O-Methylnaltrexone;4,5α-Epoxy-3-methoxy-14β-hydroxy-17-(cyclopropylmethyl)morphinan-6-one;Naltrexone methyl ether;17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium;17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinanium-6-one | | CAS: | 83387-25-1 | | MF: | C21H26NO4+ | | MW: | 356.43544 | | EINECS: | | | Mol File: | 83387-25-1.mol |  |
Use
Methylnaltrexone (Relistor) is the methylated, quaternaryform of naltrexone . The permanently chargednitrogen prevents the drug from crossing the blood-brainbarrier. Thus, it only acts as an antagonist at peripheralopioid receptors. Relistor was approved in April 2008 totreat opioid-induced constipation in patients receiving palliativecare. It is administered as a SC injection once everyother day.
- Methylnaltrexone
-
- US $1520.00-2500.00 / mg
- 2024-10-24
- CAS:83387-25-1
- Min. Order:
- Purity:
- Supply Ability: 10g
|
|
83387-25-1
Recommend Suppliers |
1
|